InvestorsHub Logo
Post# of 4970796
Next 10
Followers 4
Posts 179
Boards Moderated 0
Alias Born 02/25/2012

Re: palob post# 3709473

Wednesday, 07/01/2015 12:17:02 PM

Wednesday, July 01, 2015 12:17:02 PM

Post# of 4970796
ELTP_ GET IN AT THE BOTTOM!!!!
$15 million in milestones timed and frontloaded as they are, provides us with much needed funding for the continued and expedited development of additional Abuse-Deterrent opioid products
.
Just a few more quick points on our financials, if you look at our cash flow statement you’ll see we’re reporting an operating cash burn of $15.1 million and also our P&L statement shows $14.8 million in R&D expense. So, if you put these two numbers together, this statement show that the cash burn is due to the R&D costs, not really a surprise there. These R&D costs are however starting to really pay off for us.
.
Our working capital was $7.3 million, our cash-on-hand was $7.5 million and all of our liabilities including the New Jersey Economic Development bonds were in compliance. So all of the defaults of the past has been resolved, they are all in the past.
.
We had record revenues for the second straight year, we booked $5 million for the first time, our generic products continue to perform well and we still have a robust pipeline to provide future increases and expansion.
http://investorshub.advfn.com/boards/board.aspx?board_id=15170

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.